BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 15822466)

  • 1. [Erysipelas. Retrospective study of 647 patients].
    Zaraa I; Zeglaoui F; Zouari B; Ezzine N; Fazaa B; Kamoun MR
    Tunis Med; 2004 Nov; 82(11):990-5. PubMed ID: 15822466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erysipelas: epidemiological, clinical and therapeutic data (111 cases)].
    Crickx B; Chevron F; Sigal-Nahum M; Bilet S; Faucher F; Picard C; Lazareth I; Belaich S
    Ann Dermatol Venereol; 1991; 118(1):11-6. PubMed ID: 2018300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacterial dermohypodermitis and necrotizing fascitis: 104-case series from Togo].
    Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Boukari T; Pitché P; Tchangaï-Walla K
    Med Trop (Mars); 2011 Apr; 71(2):162-4. PubMed ID: 21695874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent erysipelas: 47 cases.
    Leclerc S; Teixeira A; Mahé E; Descamps V; Crickx B; Chosidow O
    Dermatology; 2007; 214(1):52-7. PubMed ID: 17191048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital.
    Lazzarini L; Conti E; Tositti G; de Lalla F
    J Infect; 2005 Dec; 51(5):383-9. PubMed ID: 16321649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology, clinical features, and evolution of Erysipelas in the Marrakech region (100 cases)].
    Amal S; Houass S; Laissaoui K; Moufid K; Trabelsi M
    Med Mal Infect; 2004 Apr; 34(4):171-6. PubMed ID: 15619888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erysipelas of the leg in hospital environment in Lome (Togo)].
    Pitche P; Tchangaï-Walla K
    Bull Soc Pathol Exot; 1997; 90(3):189-91. PubMed ID: 9410258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy and prophylaxis of recurrent erysipelas (author's transl)].
    Ziebart-Schroth A
    Med Klin; 1976 Jul; 71():1197-9. PubMed ID: 822266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erysipelas in the young population of a military hospital].
    Mahé E; Toussaint P; Lamarque D; Boutchnei S; Guiguen Y
    Ann Dermatol Venereol; 1999; 126(8-9):593-9. PubMed ID: 10530346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic use in patients with erysipelas: a retrospective study.
    Bishara J; Golan-Cohen A; Robenshtok E; Leibovici L; Pitlik S
    Isr Med Assoc J; 2001 Oct; 3(10):722-4. PubMed ID: 11692544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular bipenicillin vs. intravenous penicillin in the treatment of erysipelas in adults: randomized controlled study.
    Zeglaoui F; Dziri C; Mokhtar I; Ezzine N; Kharfi M; Zghal M; Fazaa B; Kamoun MR
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):426-8. PubMed ID: 15196155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demographic, clinical and laboratory characteristics of erisypelas in the period 2001-2010].
    Vâţă D; Solovăstru LG; Vâţă A; Dorobăţ C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1042-7. PubMed ID: 22276443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary and secondary prevention for erysipelas].
    Becq-Giraudon B
    Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):368-75. PubMed ID: 11319367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study.
    Vignes S; Dupuy A
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):818-22. PubMed ID: 16898904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erysipelas and cellulitis: a retrospective study of 122 cases].
    Concheiro J; Loureiro M; González-Vilas D; García-Gavín J; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2009 Dec; 100(10):888-94. PubMed ID: 20038366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intralymphatic antibiotic therapy in erysipelas of the lower limbs].
    Ermolov AS; Cherkasov VL; Udovskiĭ EE; Samotolkin KN; Ryskind RR; Grigorian AR; Mamedov BA
    Sov Med; 1989; (8):95-9. PubMed ID: 2814680
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiological data and comorbidities of 428 patients hospitalized with erysipelas.
    Pereira de Godoy JM; Galacini Massari P; Yoshino Rosinha M; Marinelli Brandão R; Foroni Casas AL
    Angiology; 2010 Jul; 61(5):492-4. PubMed ID: 20147345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erysipelas--course of disease, recurrence, complications; a 10 years retrospective study].
    Wojas-Pelc A; Alekseenko A; Jaworek AK
    Przegl Epidemiol; 2007; 61(3):457-64. PubMed ID: 18069381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erysipelas at the dermatological clinic in Mannheim 1960-1975].
    Bertsch O; Bojanovsky A; Jung EG
    Z Hautkr; 1977 Sep; 52(17):885-9. PubMed ID: 910535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzathine penicillin G once-every-3-week prophylaxis for recurrent erysipelas a retrospective study of 132 patients.
    Rob F; Hercogová J
    J Dermatolog Treat; 2018 Feb; 29(1):39-43. PubMed ID: 28489486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.